Johnson & Johnson highlighted growth opportunities within the MedTech sector.
1 report, 1 independent
Updated Sep 10
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Johnson & Johnson highlighted growth opportunities within the MedTech sector.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Johnson & Johnson
U.S multinational medical devices, pharmaceutical and consumer packaged goods manufacturer
-
Medtech
medical education facility founded in 2004 in Indianapolis, U.S
Related events
- MedTech is identified as a soft spot in J&J case.
- Medical device sales are up in the U.S., but major players like J&J are facing market headwinds due to the VBP program in China.
- Johnson & Johnson is reportedly considering a sale of its orthopedics business unit within DePuy Synthes.
- Johnson & Johnson, UnitedHealth Group, and Intuitive Surgical are noted as major players in the high-volume U.S. healthcare sector.
- Eli Lilly outperformed Johnson & Johnson stock over the past year.